Specifically, no or low tumor expression of PD-L1 (p < 0.001), Gal-9 (p < 0.001) and HVEM (p < 0.001) was associated with poor HCC-specific survival, while expression of IDO was not associated with HCC-specific survival (p = 0.953). The gene discussed is LGALS9; the disease is neoplasm.